Product Images Aciphex
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Aciphex NDC 80725-243 by Waylis Therapeutics Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - aciphex 01
Figure 2 - aciphex 02
Figure 3 - aciphex 03
This is a study evaluating the mean scores of heartburn at different doses of RAB (10mg and 20mg) compared to a placebo. The heartburn scores range from 0 (none) to 4 (very severe). The study includes a total of 131 participants (64 in the 10mg group and 67 in the 20mg group). The graph represents the heartburn scores over a period of 28 days.*
Figure 4 - aciphex 04
Figure 5 - aciphex 05
This text provides information about a study evaluating the mean scores for two groups: "PLACEBO" (n=58) and "RAB20mg" (n=59). The study measures heartburn scores on a scale of 0 to 4, with 0 indicating no heartburn and 4 indicating very severe heartburn. Unfortunately, the specific mean scores are not available in the provided text.*
PRINCIPAL DISPLAY PANEL - 30 Tablet Bottle Label - aciphex 06
This text appears to be a label or information regarding a medication called AcipHex. It provides dosing instructions and storage information. The medication is in the form of delayed-release tablets. It is distributed by Waylis Therapeutics LLC in Wicom, MI with an expiration date of 2023. The NDC (National Drug Code) for this medication is 80725-243-30.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.